Skip to main content

Table 1 Hepatitis C-related characteristics among HCV antibody positive and negative PWID

From: Prevalence of and risk factors for hepatitis C virus antibody among people who inject drugs in Cambodia: a national biological and behavioral survey

Hepatitis C-related characteristics

Total (n = 286)

HCV antibody test result

Positive (n = 87)

Negative (n = 199)

n (%)

n (%)

n (%)

Tested for HCV in lifetime

61 (21.3)

28 (32.2)

33 (16.6)

Tested for HCV in the past 12 months (n = 61)

47 (77.0)

22 (78.6)

25 (75.8)

Diagnosed or told about having hepatitis C (n = 61)

16 (26.2)

10 (35.7)

6 (18.2)

Currently on hepatitis C treatment (n = 16)

8 (50.0)

5 (50.0)

3 (50.0)

Received education on hepatitis C in the past 12 months

45 (15.8)

17 (19.5)

28 (14.1)

Source of information on hepatitis C received last time

 Peer educator/outreach worker

23 (50.0)

7 (41.2)

16 (55.2)

 Drop-in center

27 (58.7)

13 (76.5)

14 (43.3)

Perceived HCV risk compared to the general population

 Higher

59 (20.8)

24 (27.6)

35 (17.8)

 About the same

75 (26.4)

21 (24.1)

64 (27.4)

 Lower

32 (11.3)

6 (6.9)

26 (13.2)

 Do not know

118 (41.5)

36 (41.4)

82 (41.6)

  1. HCV hepatitis C virus, PWID people who inject drugs
  2. Chi-square (or Fisher’s exact test when a cell count was smaller than 5) was used